Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score.
Gragnano F, Jolly SS, Mehta SR, Branca M, van Klaveren D, Frigoli E, Gargiulo G, Leonardi S, Vranckx P, Di Maio D, Monda E, Fimiani L, Fioretti V, Chianese S, Andò G, Esposito G, Sangiorgi GM, Biondi-Zoccai G, Heg D, Calabrò P, Windecker S, Romagnoli E, Valgimigli M. Gragnano F, et al. Among authors: van klaveren d. EuroIntervention. 2021 Dec 17;17(12):e971-e980. doi: 10.4244/EIJ-D-21-00441. EuroIntervention. 2021. PMID: 34374343 Free PMC article. Clinical Trial.
Performance metrics for models designed to predict treatment effect.
Maas CCHM, Kent DM, Hughes MC, Dekker R, Lingsma HF, van Klaveren D. Maas CCHM, et al. Among authors: van klaveren d. BMC Med Res Methodol. 2023 Jul 8;23(1):165. doi: 10.1186/s12874-023-01974-w. BMC Med Res Methodol. 2023. PMID: 37422647 Free PMC article.
External validation of 18 F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy.
Valkema MJ, Beukinga RJ, Chatterjee A, Woodruff HC, van Klaveren D, Noordzij W, Valkema R, Bennink RJ, Roef MJ, Schreurs W, Doukas M, Lagarde SM, Wijnhoven BPL, Lambin P, Plukker JTM, van Lanschot JJB. Valkema MJ, et al. Among authors: van klaveren d, van lanschot jjb. Nucl Med Commun. 2023 Aug 1;44(8):709-718. doi: 10.1097/MNM.0000000000001707. Epub 2023 May 3. Nucl Med Commun. 2023. PMID: 37132272 Free PMC article.
Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials.
Iqbal J, Vergouwe Y, Bourantas CV, van Klaveren D, Zhang YJ, Campos CM, García-García HM, Morel MA, Valgimigli M, Windecker S, Steyerberg EW, Serruys PW. Iqbal J, et al. Among authors: van klaveren d. JACC Cardiovasc Interv. 2014 May;7(5):464-70. doi: 10.1016/j.jcin.2014.02.007. JACC Cardiovasc Interv. 2014. PMID: 24852801 Free article.
Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials.
Campos CM, Garcia-Garcia HM, van Klaveren D, Ishibashi Y, Cho YK, Valgimigli M, Räber L, Jonker H, Onuma Y, Farooq V, Garg S, Windecker S, Morel MA, Steyerberg EW, Serruys PW. Campos CM, et al. Among authors: van klaveren d. Int J Cardiol. 2015;187:111-5. doi: 10.1016/j.ijcard.2015.03.248. Epub 2015 Mar 18. Int J Cardiol. 2015. PMID: 25828327 Clinical Trial.
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators. Costa F, et al. Among authors: van klaveren d. Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5. Lancet. 2017. PMID: 28290994 Review.
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
Costa F, Van Klaveren D, Feres F, James S, Räber L, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators. Costa F, et al. Among authors: van klaveren d. J Am Coll Cardiol. 2019 Feb 26;73(7):741-754. doi: 10.1016/j.jacc.2018.11.048. J Am Coll Cardiol. 2019. PMID: 30784667 Free article.
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.
Chichareon P, Modolo R, van Klaveren D, Takahashi K, Kogame N, Chang CC, Katagiri Y, Tomaniak M, Asano T, Spitzer E, Buszman P, Prokopczuk J, Fath-Ordoubadi F, Buysschaert I, Anderson R, Oldroyd KG, Merkely B, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Onuma Y, Serruys PW. Chichareon P, et al. Among authors: van klaveren d. Int J Cardiol. 2019 Jul 1;286:43-50. doi: 10.1016/j.ijcard.2019.02.043. Epub 2019 Feb 20. Int J Cardiol. 2019. PMID: 30846254 Clinical Trial.
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial.
Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Asano T, Katagiri Y, van Geuns RM, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek JJ, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys PW. Chichareon P, et al. Among authors: van klaveren d, van geuns rm. EuroIntervention. 2019 Aug 9;15(6):e539-e546. doi: 10.4244/EIJ-D-19-00184. EuroIntervention. 2019. PMID: 31217143 Free article. Clinical Trial.
128 results